Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Am J Obstet Gynecol. 2013 Oct;209(4):363.e1-5. doi: 10.1016/j.ajog.2013.06.008. Epub 2013 Jun 13.
We sought to determine the frequency of laboratory studies after female pelvic reconstructive surgery and the rate of intervention based on the results of these laboratory values at a single institution.
We conducted a retrospective review of all patients undergoing female pelvic reconstructive surgery for pelvic organ prolapse by 5 fellowship-trained pelvic reconstructive surgeons at a single institution from Jan. 1, 2010, through Dec. 31, 2010. Exclusion criteria were outpatient procedures, isolated hysterectomy, and a combined surgery with another surgical team performing a separate procedure. Interventions based on the number of laboratory studies were classified as minor (electrolyte repletion, repeat laboratory tests, initiation of antibiotics) or major (transfusion, delayed discharge).
A total of 356 patients were included in the final dataset and 100% of patients had routine postoperative laboratory studies. A total of 8771 laboratory values were obtained with a mean of 25 ± 18 laboratory values (0-133) per patient. One-third of postoperative patients (n = 120) underwent a total of 207 interventions based on abnormal laboratory results. The majority of interventions were minor (96%). Of the 120 patients who had a minor intervention, electrolyte repletion was the most common (78%), followed by repeat blood collection (40%) and initiation of antibiotics (4%). The major intervention rate was 4% (n = 8) and all underwent transfusion. Of the 8 transfused patients, 7 demonstrated clinical instability before transfusion and 1 was transfused based on laboratory values and a significant cardiac history.
Routine postoperative laboratory studies are not necessary for all patients after female pelvic reconstructive surgery and more judicious use based on clinical findings may limit unnecessary minor interventions.
我们旨在确定女性盆腔重建手术后进行实验室研究的频率,并根据该机构的实验室结果对干预的频率进行评估。
我们对 2010 年 1 月 1 日至 2010 年 12 月 31 日期间,由 5 位经过妇科重建手术专科培训的外科医生进行的所有女性盆腔器官脱垂的盆腔重建手术患者进行了回顾性研究。排除标准为门诊手术、单纯子宫切除术和与另一手术团队联合进行的单独手术。根据实验室检查次数进行分类,干预措施分为小干预(电解质补充、重复实验室检查、开始使用抗生素)或大干预(输血、延迟出院)。
最终数据集包括 356 名患者,所有患者均进行常规术后实验室检查。共获得 8771 个实验室值,平均每位患者 25 ± 18 个实验室值(0-133)。三分之一的术后患者(n = 120)根据异常实验室结果共进行了 207 次干预。大多数干预措施为小干预(96%)。在 120 名接受小干预的患者中,电解质补充最为常见(78%),其次是重复采血(40%)和开始使用抗生素(4%)。大干预率为 4%(n = 8),均进行输血。在 8 名输血患者中,7 名在输血前表现出临床不稳定,1 名基于实验室值和显著的心脏病史进行输血。
并非所有女性盆腔重建手术后的患者都需要进行常规术后实验室检查,根据临床发现更明智地使用实验室检查可能会限制不必要的小干预。